Haplotype analysis of the CETP gene: Not taqIB, but the closely linked - 629→A polymorphism and a novel promoter variant are independently associated with CETP concentration

Human Molecular Genetics

Volumn 12, Issue 2, 2003, Pages 111-123

  Klerkx, Anke H E M ^a   Tanck, Michael W T ^b,c   Kastelein, John J P ^a   Molhuizen, Henri O F ^a,d   Jukema, J Wouter ^b   Zwinderman, Aeilko H ^b,c   Kuivenhoven, Jan Albert ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ANALYTIC METHOD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE COURSE; DNA POLYMORPHISM; DRUG EFFECT; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGRESSION ANALYSIS; REVIEW;

AGED; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC);

EID: 0037439546     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg013     Document Type: Review

References (56)

1. Tall, A.R. (1993) Plasma cholesteryl ester transfer protein. J. Lipid Res., 34, 1255-1274.
2. Inazu, A., Jiang, X.C., Haraki, T., Yagi, K., Kamon, N., Koizumi, J., Mabuchi, H., Takeda, R., Takata, K. and Moriyama, Y. (1994) Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest., 94, 1872-1882.
3. Zhong, S., Sharp, D.S., Grove, J.S., Bruce, C., Yano, K., Curb, J.D. and Tall, A.R. (1996) Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest., 97, 2917-2923.
4. Hirano, K., Yamashita, S. and Matsuzawa, Y. (2000) Pros and cons of inhibiting cholesteryl ester transfer protein. Curr. Opin. Lipidol., 11, 589-596.
5. Manninen, V., Elo, M.O., Frick, M.H., Haapa, K., Heinonen, O.P., Heinsalmi, P., Helo, P., Huttunen, J.K., Kaitaniemi, P., Koskinen, P. et al. (1988) Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA, 260, 641-651.
6. Bruce, C., Chouinard, R.A., Jr and Tall, A.R. (1998) Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. A. Rev. Nutr., 18, 297-330.
7. Yamashita, S., Hirano, K., Sakai, N. and Matsuzawa, Y. (2000) Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim. Biophys. Acta, 1529, 257-275.
8. Drayna, D. and Lawn, R. (1987) Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucl. Acids Res., 15, 4698.
9. Funke, H., Wiebusch, H., Fuer, L., Muntoni, S., Schulte, H. and Assmann, G. (1994) Identification of mutations in the cholesteryl ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation, 90, I-241.
10. Fumeron, F., Betoulle, D., Luc, G., Behague, I., Ricard, S., Poirier, O., Jemaa, R., Evans, A., Arveiler, D. and Marques-Vidal, P. (1995) Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest., 96, 1664-1671.
11. Corbex, M., Poirier, O., Fumeron, F., Betoulle, D., Evans, A., Ruidavets, J.B., Arveiler, D., Luc, G., Tiret, L. and Cambien, F. (2000) Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet. Epidemiol., 19, 64-80.
12. Freeman, D.J., Griffin, B.A., Holmes, A.P., Lindsay, G.M., Gaffney, D., Packard, C.J. and Shepherd, J. (1994) Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb., 14, 336-344.
13. Bernard, S., Moulin, R, Lagrost, L., Picard, S., Elchebly, M., Ponsin, G., Chapuis, F. and Berthezene, F. (1998) Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. J. Lipid Res., 39, 59-65.
14. Kuivenhoven, J.A., Jukema, J.W., Zwinderman, A.H., de Knijff, P., McPherson, R., Bruschke, A.V., Lie, K.I. and Kastelein, J.J.P. (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. New Engl. J. Med., 338, 86-93.
15. Gudnason, V., Kakko, S., Nicaud. V., Savolainen, M.J., Kesaniemi, Y.A., Tahvanainen, E. and Humphries, S. (1999) Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur. J. Clin. Invest., 29, 116-128.
16. Ordovas, J.M., Cupples, L.A., Corella, D., Otvos, J.D., Osgood, D., Martinez, A., Lahoz, C., Coltell, O., Wilson, P.W. and Schaefer, E.J. (2000) Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler. Thromb. Vasc. Biol., 20, 1323-1329.
17. Inazu, A. and Mabuchi, H. (2001) An unsolved mystery of promoter variation in CETP gene and atherosclerosis. Eur. J. Clin. Invest., 31, 558-559.
18. Corella, D., Saiz, C., Guillen, M., Portoles, O., Mulet, F., Gonzalez, J.I. and Ordovas, J.M. (2000) Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy spanish population. Atherosclerosis, 152, 367-376.
19. Meguro, S., Takei, I., Murata, M., Hirose, H., Takei, N., Mitsuyoshi, Y., Ishii, K., Oguchi, S., Shinohara, J., Takeshita, E. et al. (2001) Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis, 156, 151-156.
20. Kakko, S., Tamminen, M., Paivansalo, M., Kauma, H., Rantala, A.O., Lilja, M., Reunanen, A., Kesaniemi, Y.A. and Savolainen, M.J. (2001) Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur. J. Clin. Invest., 31, 593-602.
21. Goto, A., Sasai, K., Suzuki, S., Fukutomi, T., Ito, S., Matsushita, T., Okamoto, M., Suzuki, T., Itoh, M., Okumura-Noji, K. et al. (2001) Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. Atherosclerosis, 159, 153-163.
22. Hannuksela, M.L., Liinamaa, M.J., Kesaniemi, Y.A. and Savolainen, M.J. (1994) Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis, 110, 35-44.
23. Vohl, M.C., Lamarche, B., Pascot, A., Leroux, G., Prud'homme, D., Bouchard, C., Nadeau, A. and Despres, J.P. (1999) Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome. Int. J. Obes. Relat Metab Disord., 23, 918-925.
24. Brousseau, M.E., O'Connor, J.J., Jr, Ordovas, J.M., Collins, D., Otvos, J.D., Massov, T., McNamara, J.R., Rubins, H.B., Robins, S.J. and Schaefer, E.J. (2002) Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler. Thromb. Vasc. Biol., 22, 1148-1154.
25. Kuivenhoven, J.A., de Knijff, P., Boer, J.M., Smalheer, H.A., Botma, G.J., Seidell, J.C., Kastelein, J.J. and Pritchard, P.H. (1997) Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb. Vasc. Biol., 17, 560-568.
26. Dachet, C., Poirier, O., Cambien, F., Chapman, J. and Rouis, M. (2000) New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb. Vasc. Biol., 20, 507-515.
27. Jukema, J.W., Bruschke, A.V., van Boven, A.J., Reiber, J.H., Bal, E.T., Zwinderman, A.H., Jansen, H., Boerma, G.J., van Rappard, F.M. and Lie, K.I. (1995) Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation, 91, 2528-2540.
28. Tanck, M.W.T., Jukema, J.W., Klerkx, A.H.E.M., Kuivenhoven, J.A., de Knijff, P. and Zwinderman, A.H. (2001) A novel method to estimate haplotype effects in patient populations. Circulation, 104 (Suppl. II), 828.
29. Chang, D.J., Paik, Y.K., Leren, T.P., Walker, D.W., Howlett, G.J. and Taylor, J.M. (1990) Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors. J. Biol. Chem., 265, 9496-9504.
30. Paulweber, B., Onasch, M.A., Nagy, B.P. and Levy-Wilson, B. (1991) Similarities and differences in the function of regulatory elements at the 5′ end of the human apolipoprotein B gene in cultured hepatoma (HepG2) and colon carcinoma (CaCo-2) cells. J. Biol. Chem., 266, 24149-24160.
31. Heinemeyer, T., Wingender, E., Reuter, I., Hermjakob, H., Kel, A.E., Kel, O.V., Ignatieva, E.V., Ananko, E.A., Podkolodnaya, O.A., Kolpakov, F.A. et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucl. Acids Res., 26, 362-367.
32. Le Goff, W., Guerin, M., Nicaud, V., Dachet, C., Luc, G., Arveiler, D., Ruidavets, J.B., Evans, A., Kee, F., Morrison, C. et al. (2002) A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the TaqIB; and -629C/A polymorphisms. Atherosclerosis, 161, 269-279.
33. Jiang, X.C., Moulin, P., Quinet, E., Goldberg, I.J., Yacoub, L.K., Agellon, L.B., Compton, D., Schnitzer-Polokoff, R. and Tall, A.R. (1991) Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J. Biol. Chem., 266, 4631-4639.
34. Richardson, M.A., Berg, D.T., Johnston, P.A., McClure, D. and Grinnell, B.W. (1996) Human liposarcoma cell line, SW872, secretes cholesteryl ester transfer protein in response to cholesterol. J. Lipid Res., 37, 1162-1166.
35. Gauthier, B., Robb, M., Gaudet, F., Ginsburg, G.S. and McPherson, R. (1999) Characterization of a cholesterol response element (CRE) in the promoter of the cholesteryl ester transfer protein gene: functional role of the transcription factors SREBP-1a, -2, and YY1. J. Lipid Res., 40, 1284-1293.
36. Luo, Y. and Tall, A.R. (2000) Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J. Clin. Invest., 105, 513-520.
37. Izem, L. and Morton, R.E. (2001) Cholesteryl ester transfer protein biosynthesis and cellular cholesterol homeostasis are tightly interconnected. J. Biol. Chem., 276, 26534-26541.
38. Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K. and Shinkai, H. (2000) A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature, 406, 203-207.
39. de Grooth, G.J., Kuivenhoven, J.A., Stalenhoef, A.F., de Graaf, J., Zwinderman, A.H., Posma, J.L., van Tol, A. and Kastelein, J.J. (2002) Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation, 105, 2159-2165.
40. Von Eckardstein, A., Nofer, J.R. and Assmann, G. (2001) High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb. Vasc. Biol., 21, 13-27.
41. Villard, E., Tiret, L., Visvikis, S., Rakotovao, R., Cambien, F. and Soubrier, F. (1996) Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am. J. Hum. Genet., 58, 1268-1278.
42. Tregouet, D.A., Barbaux, S., Escolano, S., Tahri, N., Golmard, J.L., Tiret, L. and Cambien, F. (2002) Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum. Mol. Genet., 11, 2015-2023.
43. Eiriksdottir, G., Bolla, M.K., Thorsson, B., Sigurdsson, G., Humphries, S.E. and Gudnason, V. (2001) The -629C > A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis, 159, 187-192.
44. Niemeijer-Kanters, S.D., Dallinga-Thie, G.M., Ruijter-Heijstek, F.C., Algra, A., Erkelens, D.W., Banga, J.D. and Jansen, H. (2001) Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus. Atherosclerosis, 156, 209-216.
45. Guo, S.W. and Thompson, E.A. (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics, 48, 361-372.
46. Slatkin, M. and Excoffier, L. (1996) Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity, 76 (Pt 4), 377-383.
47. Schneider, S., Roessli, D., and Excoffier, L. (2000) Arlequin ver. 2.000: a Software for Population Genetics Data Analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland.
48. Thompson, E.A., Deeb, S., Walker, D. and Motulsky, A.G. (1988) The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet., 42, 113-124.
49. Excoffier, L. and Slatkin, M. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
50. Templeton, A.R. (1987) The general relationship between average effect and average excess. Genet. Res., 49, 69-70.
51. Thomas, D.C., Morrison, J.L. and Clayton, D.G. (2001) Bayes estimates of haplotype effects. Genet. Epidemiol., 21 (Suppl. 1), S712-S717.
52. Eilers, P.H.C. and Marx, B.D. (1996) Flexible smoothing with B-splines and penalties. Stat. Sci., 11, 89-102.
53. Golub, G.H., Heath, M. and Wahba, G. (1979) Generalized cross-validation as a method for choosing a good ridge parameter. Technometrics, 21, 215-223.
54. Louis, T.A. (1982) Finding the observed information matrix when using the EM algorithm. J. Stat. Soc. Ser. B, 44, 226-233.
55. Akaike, H. (1973) Information theory and an extension of the maximum likelihood principle. Proceeding of 2nd International Symposium on Information Theory, Suppl. Problems of Control and Information Theory, 267-281.
56. Talmud, P.J., Edwards, K.L., Turner, C.M., Newman, B., Palmen, J.M., Humphries, S.E. and Austin, M.A. (2000) Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetra-nucleotide repeat within the CETP promoter. Circulation, 101, 2461-2466.